Randomly, half of the patients will have an FDA-approved AI tool assist a radiologist in analyzing the data, while the other half will go through routine screening without the AI tool.
MADISON, Wis. (WMTV) – UW Health is participating in a trial to test how artificial intelligence can help radiologists detect breast cancer earlier and more accurately.
The PRISM Trial (Pragmatic Randomized Trial of Artificial Intelligence for Screen… [3047 chars]
Source: WEAU | Published: 2025-10-18T04:06:07Z
Credit: WEAU
